Contrast Induced Nephropathy (CIN) Terminated Phase 1 Trials for Acetylcysteine (DB06151)

Also known as: Contrast Induced Nephropathy

IndicationStatusPhase
DBCOND0066353 (Contrast Induced Nephropathy (CIN))Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00575419Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal FailurePrevention